Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sutent Adjunctive Treatment of Differentiated Thyroid Cancer

NCT00668811 is registered in ClinicalTrials.gov with Medstar Health Research Institute as lead sponsor.

NCT NCT00668811
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00668811 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sutent Adjunctive Treatment of Differentiated Thyroid Cancer
Lead sponsor
Medstar Health Research Institute
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2008
Completion date
December 31, 2015
Enrollment
23 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

differentiated thyroid cancer, follicular thyroid cancer, papillary thyroid cancer